AscellaHealth Leaders Take the Stage at SIIA National Conference: Present Strategies for Managing High-Cost Claims and Building Pharma Partnerships
BERWYN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner…
Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer
Board-certified oncologist who brings over 20 years of senior clinical development experience…
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
Hinge Bio to receive $10 million upfront and is eligible to receive…
Viva Biotech Receives Frost & Sullivan’s 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry
Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that…
Artelo Biosciences Announces Proposed Underwritten Public Offering
September 29, 2025 19:15 ET | Source: Artelo Biosciences SOLANA BEACH, Calif.,…
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman
Tesla Robotics to Power Sovereign “Seed to Syringe” Pharmaceutical Infrastructure Fort Lauderdale,…
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by…
Gateway to Growth: Innovation and Opportunity at the 8th CIIE
SHANGHAI, Aug. 29, 2025 /PRNewswire/ -- Amid a shifting global economy, the China…